Drugs / GP30341
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05648799 | Mar → May 2022 | — | Geropharm | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GP30341 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05648799 ↗ |
| Route | Oral | “orall take of capsules twice a day” NCT05648799 ↗ |